Cypher cardiovascular data

In the SISR trial in 384 patients, Cypher met the primary endpoint with a 9-month TVF rate of 12.4% vs. 21.6% for intravascular brachytherapy (p=0.023). Acute gain post-procedure for Cypher was 1.27 m...